Takeda, JCR Pharma join hands to commercialize Hunter Syndrome Therapy
Osaka: Takeda Pharmaceutical Company Limited and JCR Pharmaceuticals Co., Ltd. (JCR) have announced a geographically-focused exclusive collaboration and license agreement to commercialize JR-141 (INN:...
Source: medicaldialogues.in